Name: BioAge Labs, Inc. (BIOA) Balance Sheet
Creator: FinSpry

BioAge Labs Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BioAge Labs, Inc. (BIOA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	354.35	21.64	27.64
Cash & Short-Term Investments	354.35	21.64	27.64
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	2.75	0.35	0.39
Total Current Assets	357.10	25.31	28.03
Non-Current Assets
Property, Plant & Equipment (Net)	0.79	0.52	0.37
Long-Term Investments	0.10	0.10	0.00
Other Non-Current Assets	0.24	0.00	0.03
Total Non-Current Assets	1.13	0.62	0.40
Total Assets	358.23	25.92	28.43
Current Liabilities
Accounts Payable	2.00	1.87	2.26
Short-Term Debt	6.20	44.86	0.17
Current Portion of Long-Term Debt	6.00	6.00	0.17
Accrued Liabilities	11.33	6.55	3.36
Deferred Revenue	7.83	3.31	0.00
Other Current Liabilities	11.75	1.39	0.02
Total Current Liabilities	27.78	58.17	5.86
Non-Current Liabilities
Long-Term Debt	2.50	8.20	2.25
Other Non-Current Liabilities	0.16	0.23	0.15
Total Non-Current Liabilities	7.33	141.15	135.13
Total Liabilities	35.11	199.32	8.27
Stockholders' Equity
Retained Earnings	-252.81	-181.70	-117.85
Accumulated Other Comprehensive Income	0.25	0.16	0.17
Additional Paid-in Capital	575.69	8.14	5.12
Shares Outstanding	35.85	34.17	34.17
Total Stockholders' Equity	323.13	-173.40	20.16
Total Liabilities & Equity	358.23	25.92	28.43